According to Immunic's latest financial reports the company's current EPS (TTM) is -3,04 โฌ. In 2022 the company made an earnings per share (EPS) of -3,34 โฌ an increase over its 2021 EPS that were of -3,37 โฌ.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -3,24 โฌ | -2.88% |
2022 | -3,34 โฌ | -1.05% |
2021 | -3,37 โฌ | 33.68% |
2020 | -2,52 โฌ | -64.33% |
2019 | -7,07 โฌ | -79.62% |
2018 | -34,70 โฌ | -26.32% |
2017 | -47,09 โฌ | 2.31% |
2016 | -46,03 โฌ | -38.1% |
2015 | -74,36 โฌ | -23.48% |
2014 | -97,17 โฌ | -88.9% |
2013 | -875,80 โฌ |